Assessing Value, Budget Impact and Affordability to Inform Discussions on Access and Reimbursement: Principles and Practice, with Special Reference to High Cost Technologies
Assessing Value, Budget Impact and Affordability to Inform Discussions on Access and Reimbursement: Principles and Practice, with Special Reference to High Cost Technologies
复制标题
评估价值、预算影响和承受能力，为有关获取和报销的讨论提供信息：原则和实践，特别是高成本技术
DOI：
--
复制
发表时间：
2017
期刊：
影响因子：
--
通讯作者：
C. Henshall
中科院分区：
文献类型：
--
作者：
G. Hampson;A. Towse;C. Henshall
HTAI亚洲政策论坛2016年会议于2016年11月17日至18日在吉隆坡举行。会议的主题是-评估价值、预算影响和负担能力，为关于获取和偿还的讨论提供信息-原则和做法，特别是高成本技术。本报告是该会议的背景文件，由人权高专办编写。本文首先讨论了如何定义、衡量价值并将其纳入关于获取和覆盖的决定。接下来，本文将探讨如何定义和衡量预算影响和可负担性-我们将解释不同国家如何采用不同的方法来确定预算影响如何以及何时纳入决策过程，并概述围绕可负担性挑战的几种不同情景。最后一节考虑了高成本干预措施是否需要新的评估和/或报销方法，借鉴了最近Sovaldi治疗丙型肝炎的高调例子。还提供了[2013]（https：//www.ohe.org/publications/hta-and-decision-making-asia-how-can-available-resources-be-used-most-effectively#overlay-context=publications/transferability-hta）、[2014]（https：//www.ohe.org/publications/transferability-hta#overlay-context=publications）和[2015]（https：//www.ohe.org/publications/how-can-hta-meet-needs-health-system-and-government-decision-makers）会议的背景文件。请注意[这次会议的报告]（https：//www.剑桥.org/core/journals/international-journal-of-technology-assessment-in-health-care/article/assessing-value-approximat-impact-and-affiliate-in-asia/4 E4 E7 B24262 B1 A7 D12 CF 3E 63824 D5 EC 6）也发表在《国际医疗技术评估杂志》上。
The 2016 meeting of the HTAi Asia Policy Forum meeting was held in Kuala Lumpur, 17th -18th November 2016. The topic of the meeting was - Assessing Value, Budget Impact and Affordability to Inform Discussions on Access and Reimbursement - Principles and Practice, with Special Reference to High Cost Technologies. This report represents the background paper for the meeting, as developed by OHE. The paper begins with a discussion of how value can be defined, measured and factored into decisions on access and coverage. Next, the paper looks at how budget impact and affordability can be defined and measured - we explain how different countries have adopted different approaches to how and when budget impact has been included within the decision making process, and outline several different scenarios around affordability challenges. The final section considers whether high cost interventions call for new approaches to assessment and/or reimbursement, drawing on the recent high profile example of Sovaldi for the treatment of Hepatitis C. The background papers from the [2013]( https://www.ohe.org/publications/hta-and-decision-making-asia-how-can-available-resources-be-used-most-effectively#overlay-context=publications/transferability-hta), [2014]( https://www.ohe.org/publications/transferability-hta#overlay-context=publications) and [2015]( https://www.ohe.org/publications/how-can-hta-meet-needs-health-system-and-government-decision-makers) meeting are also available. Please note [a report of this meeting]( https://www.cambridge.org/core/journals/international-journal-of-technology-assessment-in-health-care/article/assessing-value-budget-impact-and-affordability-in-asia/4E4E7B24262B1A7D12CF3E63824D5EC6)has also been published in the International Journal of Technology Assessment in Health Care.